EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access

The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study

Ivan Chun Hang Lam iD, Yi Chai, Kenneth Keng Cheung Man iD, Wallis Cheuk Yin Lau, Hao Luo, Xiaoyu Lin, Can Yin, Celine Sze Ling Chui, Xue Li, Qingpeng Zhang, Esther Wai Yin Chan, Eric Yuk Fai Wan iD und 1 weitere

Journal of the Royal Society of Medicine · 2025-07 · 118 (7) · 213-229

DOI: 10.1177/01410768251352666 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the Royal Society of Medicine, online erschienen am 08.07.2025. Verfasst von Ivan Chun Hang Lam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Collaborative Research Fund, Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To generate comprehensive evidence on the risk of clinical sequelae involving different organ systems over time after coronavirus disease 2019 (COVID-19) infection.

Design

Multinational retrospective cohort study.

Setting

Electronic medical records from the US, UK, France, Germany and Italy standardised to the Observational Medical Outcomes Partnership Common Data Model.

Participants

A total of 303,251 individuals with a COVID-19 infection between 1 December 2019 and 1 December 2020 and propensity score matched non-COVID-19 comparators from 22,108,925 eligible candidates. Main outcome measures Incidence of 73 clinical sequelae involving multiple organ systems including the respiratory, cardiovascular, dermatological and endocrine systems over the short- (0–6 months), medium- (6–12 months) and long-term (1–2 years) after COVID-19 infection. The hazard ratio (HR) and 95% confidence interval (95% CI) of individual disease outcomes were estimated using Cox proportional hazard regression.

Results

Individuals with COVID-19 incurred a greater risk of clinical sequelae involving multiple organ systems including respiratory (France HR 2.23, 95%CI [2.10,2.37] to Italy 13.13 [11.80,14.63]), cardiovascular (Germany 1.39 [1.30,1.50] to US 1.79 [1.74,1.85]) and dermatological (UK 1.13 [1.01,1.25] to Italy 1.77 [1.42,2.21]) disorder over the short-term. While the risk of clinical sequelae has largely subsided during the medium-term, the risk of cardiovascular- (US 1.16 [1.11,1.21], France 1.10 [1.01,1.19]) and endocrine- (US 1.18 [1.12,1.24], Germany 1.15 [1.03,1.29]) related complications may continue to persist for up to two years.

Conclusions

Through a network of multinational healthcare databases, this study generated comprehensive and robust evidence supporting the extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the reduction in risk for most complications over the medium- and long-term.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCOVID-19AdultAgedFemaleHumansMaleMiddle AgedFranceRetrospective StudiesRisk FactorsSARS-CoV-2

Stichwörter der Autor:innen

COVID-19SARS-CoV-2long COVIDpost-COVID-19 conditionspost-acute sequelae of SARS-CoV-2

Autor:innen und Institutionen

  • Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford OX3 7LD, UK.
  • School of Public Health, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
  • The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong SAR, China.
  • Research Department of Practice and Policy, School of Pharmacy, University College London, London WC1N 1AX, UK.
  • Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London NW1 2PB, UK.

ORCID-Profile: Ivan Chun Hang Lam, Kenneth Keng Cheung Man, Eric Yuk Fai Wan, Ian Chi Kei Wong

Förderung

  • Collaborative Research Fund
  • Health Bureau

Zitieren

APA

Lam, I. C. H., Chai, Y., Man, K. K. C., Lau, W. C. Y., Luo, H., Lin, X., Yin, C., Chui, C. S. L., Li, X., Zhang, Q., Chan, E. W. Y., Wan, E. Y. F., & Wong, I. C. K. (2025). The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study. Journal of the Royal Society of Medicine, 118(7), 213-229. https://doi.org/10.1177/01410768251352666

Vancouver

Lam ICH, Chai Y, Man KKC, Lau WCY, Luo H, Lin X, et al. The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study. Journal of the Royal Society of Medicine. 2025;118(7):213-229. doi:10.1177/01410768251352666

BibTeX
@article{Lam2025,
  author = {Lam, Ivan Chun Hang and Chai, Yi and Man, Kenneth Keng Cheung and Lau, Wallis Cheuk Yin and Luo, Hao and Lin, Xiaoyu and Yin, Can and Chui, Celine Sze Ling and Li, Xue and Zhang, Qingpeng and Chan, Esther Wai Yin and Wan, Eric Yuk Fai and Wong, Ian Chi Kei},
  title = {The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study},
  journal = {Journal of the Royal Society of Medicine},
  year = {2025},
  volume = {118},
  number = {7},
  pages = {213--229},
  doi = {10.1177/01410768251352666}
}
Kostenlos starten →